相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence
Yuichiro Miyoshi et al.
BREAST CANCER RESEARCH (2016)
Carbon ion beam combined with cisplatin effectively disrupts triple negative breast cancer stem-like cells in vitro
Sei Sai et al.
MOLECULAR CANCER (2015)
ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype
Ying Zhong et al.
MEDICAL ONCOLOGY (2014)
Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
Suling Liu et al.
STEM CELL REPORTS (2014)
Breast Cancer Stem Cells: A Novel Therapeutic Target
Sudeshna Gangopadhyay et al.
CLINICAL BREAST CANCER (2013)
Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types
Francisco Ferro de Beca et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
Stem cells in breast tumours: Are they ready for the clinic?
Matthew P. Ablett et al.
EUROPEAN JOURNAL OF CANCER (2012)
CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma
Yan Lin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Stem cell-related markers in primary breast cancers and associated metastatic lesions
Gulnur Guler et al.
MODERN PATHOLOGY (2012)
Defining the mode of tumour growth by clonal analysis
Gregory Driessens et al.
NATURE (2012)
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen et al.
NATURE (2012)
Immunohistochemical Detection of Breast Cancer Stem Cells in Hormone Receptor-Positive Breast Cancer and Their Role in Response to Endocrine Therapy and Clinical Outcome
Kenji Hashimoto et al.
ONCOLOGY (2012)
Lineage Tracing Reveals Lgr5+ Stem Cell Activity in Mouse Intestinal Adenomas
Arnout G. Schepers et al.
SCIENCE (2012)
Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype
Sara Ricardo et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance
H. Raza Ali et al.
BREAST CANCER RESEARCH (2011)
Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content
Salvatore Pece et al.
CELL (2010)
High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability
Alysha K. Croker et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
Chad J. Creighton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
ALDH1 as a Functional Marker of Cancer Stem and Progenitor Cells
Julie Douville et al.
STEM CELLS AND DEVELOPMENT (2009)
Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype
Marija Balic et al.
CLINICAL CANCER RESEARCH (2006)
CD44(+)/CD24(-) breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis
Carol Sheridan et al.
BREAST CANCER RESEARCH (2006)
Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties
D Ponti et al.
CANCER RESEARCH (2005)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)